A former
Novartis agreed earlier this month to pay $678 million to end the suit, which claimed the drugmaker defrauded government programs like Medicare through its bribery of doctors. Sales representative Oswald Bilotta filed the suit in 2011 under the False Claims Act, which allows whistle-blowers to sue on behalf of the U.S. government and collect a percentage of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.